EP1794145 - PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.09.2012 Database last updated on 22.08.2024 | Most recent event Tooltip | 07.09.2012 | Application deemed to be withdrawn | published on 10.10.2012 [2012/41] | Applicant(s) | For all designated states Biolipox AB Berzelius väg 3, plan 5 171 65 Solna / SE | [2007/24] | Inventor(s) | 01 /
PELCMAN, Benjamin Biolipox AB Berzelius väg 3, plan 5 Solna SE-171 65 / SE | 02 /
SANIN, Andrei Biolipox AB Berzelius väg 3, plan 5 Solna SE-171 65 / SE | 03 /
NILSSON, Peter Biolipox AB Berzelius väg 3. plan 5 Solna SE-171 65 / SE | [2011/49] |
Former [2007/24] | 01 /
PELCMAN, Benjamin, Biolipox AB Berzelius väg 3, plan 5 Solna SE-171 65 / SE | ||
02 /
SANIN, Andrei, Biolipox AB Berzelius väg 3, plan 5 Solna SE-171 65 / SE | |||
03 /
NILSSON, Peter, Biolipox AB Berzelius väg 3. plan 5 Solna SE-171 65 / SE | Representative(s) | McNeeney, Stephen Phillip Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
Former [2007/24] | McNeeney, Stephen Phillip Eric Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 05784084.5 | 19.09.2005 | [2007/24] | WO2005GB03580 | Priority number, date | US20040610952P | 20.09.2004 Original published format: US 610952 P | US20040617081P | 12.10.2004 Original published format: US 617081 P | [2007/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006032851 | Date: | 30.03.2006 | Language: | EN | [2006/13] | Type: | A1 Application with search report | No.: | EP1794145 | Date: | 13.06.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.03.2006 takes the place of the publication of the European patent application. | [2007/24] | Search report(s) | International search report - published on: | EP | 30.03.2006 | Classification | IPC: | C07D401/12, C07D403/12, C07D405/12, C07D417/12, C07D495/04, C07D471/04, C07D493/04, A61P29/00, A61K31/4155 | [2007/24] | CPC: |
C07D471/04 (EP,US);
A61P1/04 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07D231/14 (EP,US);
C07D401/12 (EP,US);
C07D403/12 (EP,US);
C07D405/12 (EP,US);
C07D409/12 (EP,US);
C07D417/12 (EP,US);
C07D487/14 (EP,US);
C07D491/04 (EP,US);
C07D491/056 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/24] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | PYRAZOLVERBINDUNGEN DIE IN DER BEHANDLUNG VON ENTZÜNDUNGEN NÜTZLICH SIND | [2007/24] | English: | PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION | [2007/24] | French: | COMPOSÉS DE PYRAZOLE UTILES DANS LE TRAITEMENT D'UNE INFLAMMATION | [2007/24] | Entry into regional phase | 10.04.2007 | National basic fee paid | 10.04.2007 | Designation fee(s) paid | 10.04.2007 | Examination fee paid | Examination procedure | 04.04.2007 | Amendment by applicant (claims and/or description) | 10.04.2007 | Examination requested [2007/24] | 28.10.2009 | Despatch of a communication from the examining division (Time limit: M04) | 03.02.2010 | Reply to a communication from the examining division | 19.10.2010 | Despatch of a communication from the examining division (Time limit: M04) | 02.02.2011 | Reply to a communication from the examining division | 18.11.2011 | Communication of intention to grant the patent | 29.03.2012 | Application deemed to be withdrawn, date of legal effect [2012/41] | 11.05.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2012/41] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.10.2009 | Fees paid | Renewal fee | 12.09.2007 | Renewal fee patent year 03 | 15.09.2008 | Renewal fee patent year 04 | 11.09.2009 | Renewal fee patent year 05 | 14.09.2010 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO9841508 (SMITHKLINE BEECHAM PLC [GB], et al) [AD] 1-26 * example 60 *; | [PXD]WO2004080999 (BIOLIPOX AB [SE], et al) [PXD] 1-26 * page 20, line 13; example 78 ** page 27, line 21 - line 24; claim 53 *; | [AD] - TIHANYI E ET AL, "PYRAZOLECARBOXYLIC ACID HYDRAZIDES AS ANTIINFLAMMATORY AGENTS. NEW SELECTIVE LIPOXYGENASE INHIBITORS", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, (1984), vol. 19, no. 5, ISSN 0223-5234, pages 433 - 439, XP000942814 [AD] 1-26 * the whole document * | by applicant | WO9611917 | WO0157024 | WO0158869 | WO03020217 | WO03037274 | WO2005016877 | - TIHANYI ET AL., EUR. J MED CHEM. - CHIM. THER., (1984), vol. 19, page 433 | - GOEL ET AL., J. CHEM. INF. COMPUT. SCI., (1995), vol. 35, page 510 |